Company news
Alector, Inc. news in 2023
Alector, Inc.'s news releases, calls and decks from 2023, newest first.
Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs
November 27, 2023
Alector to Participate in the Stifel Healthcare Conference
November 7, 2023
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update
November 6, 2023
Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
October 26, 2023
Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease
September 6, 2023
Alector Reports Second Quarter 2023 Financial Results and Provides Business Update
August 2, 2023
Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
June 5, 2023
Alector Reports First Quarter 2023 Financial Results and Provides Business Update
May 3, 2023
Alector to Participate in the BofA Securities 2023 Healthcare Conference
May 1, 2023
Alector Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
February 27, 2023